Schach-Thread-Provisorium
Das wär natürlich der Hammer !!!
kommt ja noch die KE bei Nikola…mal abwarten und Tee trinken, das mach ich nämlich gerade,
Earl Grey mit Kaffeerahm
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Avinger, Inc. (AVGR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Quote Lookup
2.6700-0.2400 (-8.25%)
At close: 04:00PM EDT
die hier aus israel hab ich auch auf der watch,sehr interessant find ich die:
CollPlant Biotechnologies Ltd. (CLGN)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Quote Lookup
9.24-0.25 (-2.63%)
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel
PainReform Ltd. (PRFX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Quote Lookup
0.8820-0.0635 (-6.72%)
At close: 04:00PM EDT
ja,genau,woher kennst du organovo ? die hab ich damals in den pinks identifiziert und als erster hier bei ariva vorgestellt,aber collplant macht schon umsaetze.....
irgendwie das Hirn rüberbringen. Ich denke aber dass es anders herum laufen wird, indem man den
eigenen Körper mit einer Therapie wieder verjüngt und Organe nach Bedarf repliziert und mechanisch
optimiert, auch das Gehirn wird eines Tages wie im Internet, mit anderen Menschen, Computern vernetzt werden…nimmt mich auch Wunder was aus der Idee des Quantencomputers eines Tages für Möglichkeiten entstehen…Reisen durch die Unendlichkeit mit reiner Vorstellungskraft
PolarityTE, Inc. (PTE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Quote Lookup
0.1888+0.0023 (+1.23%)
At close: 04:00PM EDT
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
ne,es besteht im moment die anggst das polarity nicht genug kohle hat um 2 mal phase 3 zu stemmen,aber die machen auch schon knapp 10 mio umsatz ....
…weil der Kurs so tief gefallen…noch 19 Cent, hatten auch schon Resplits hinter sich,
highrisk, aber gute Umsätze